TransEnterix Provides Preliminary 2020 Year-End Corporate Update
Posted on 252 TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today provided a preliminary 2020 year-end corporate update. Recent Highlights Senhance® Surgical System received its registration certificate by the Russian medical device regulatory agency, Roszdravnadzor, allowing for its sale and utilization throughout the Russian Federation Southern Surgical Hospital, a hospital based in Louisiana, entered i...